Black Rock Inc. Ocugen, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OCGN
# of Institutions
118Shares Held
75.1MCall Options Held
200KPut Options Held
151K-
Vanguard Group Inc Valley Forge, PA16.7MShares$18.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$7.51 Million0.0% of portfolio
-
State Street Corp Boston, MA5.93MShares$6.47 Million0.0% of portfolio
-
Ubs Group Ag4.37MShares$4.76 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.53 Million0.16% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $236M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...